Utilizing multiple influenza antigens, scientists demonstrated the suitability of the mRNA therapeutic platform for such applications.
[NPJ Vaccines]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Immunology of Infectious Disease News Development of Multivalent mRNA Vaccine Candidates for Seasonal or Pandemic Influenza
